Efficacy of Favipiravir Against Severe Ebola Virus Disease
Clinical trial NCT02662855 · COMPLETED
Trial details
- NCT number
- NCT02662855
- Sponsor
- Beijing Institute of Pharmacology and Toxicology
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-04-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.